SKYA vs ACU vs BDX Stock Comparison

SkyAI, Acme United and Becton Dickinson Prices as of Oct 28, 2026 Peers: Industry group
SKYA SkyAI, Inc.
$2.95 +66.7% 1M -42.7% 1Y
Market cap
$212.68M
P/E
–
Revenue (TTM)
$194.22K
Div. yield
–
Medical Supplies Healthcare
2 wins
ACU Acme United Corp
$66.87 +5.1% 1M +73.3% 1Y
Market cap
$256.37M
P/E
24.8x
Revenue (TTM)
—
Div. yield
0.96%
Medical Supplies Healthcare
5 wins
BDX Becton Dickinson & Co
$195.18 +6.1% 1M +6.0% 1Y
Market cap
$53.16B
P/E
57.0x
Revenue (TTM)
$23.25B
Div. yield
2.15%
Medical Supplies Healthcare
3 wins

Head to Head

10 decided of 12

Acme United leads on 5 of the 12 questions below (Acme United 5, Becton Dickinson 3, SkyAI 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionSKYAACUBDXLeader
Larger companyMarket capitalisation $212.68M $256.37M $53.16B BDX
Cheaper on earningsLower P/E, profitable companies only -0.7x 24.8x 57.0x ACU
Cheaper on forward earningsLower price / next fiscal year consensus EPS 0.0x 24.3x 15.0x SKYA
Faster revenue growthRevenue growth, trailing twelve months +108.9% — +17.4% SKYA
More profitableNet margin, trailing twelve months -158,431.4% — 4.0% BDX
Better return on capitalReturn on invested capital — — 5.3% –
Less leveragedLower net debt / EBITDA — — 3.2x –
Higher dividend yieldTrailing dividend yield — 0.96% 2.15% BDX
Better 1-year returnPrice return, last 12 months -42.7% +73.3% +6.0% ACU
Better 5-year returnAnnualised price return, 5 years — +12.6%/yr -4.0%/yr ACU
Less volatileAnnualised volatility, 1 year 105.9% 30.7% 31.8% ACU
Higher overall scoreMean of the five percentile scores vs peers 26/100 71/100 68/100 ACU

Percentile Scorecard

SKYAACUBDX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisSKYAACUBDX
Valuation 2 #222 of 227 88 #28 of 227 90 #23 of 227
Growth 7 #204 of 219 – 48 #115 of 219
Profitability 1 #203 of 205 – 78 #45 of 205
Financial Health 95 #14 of 237 60 #96 of 237 27 #173 of 237
Shareholder Returns – 65 #48 of 135 96 #7 of 135
Overall 26 71 68
  • SKYA ranked among 247 companies in Medical Devices and Diagnostics
  • ACU ranked among 247 companies in Medical Devices and Diagnostics
  • BDX ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodSKYAACUBDXSPY
1 month +66.7%+5.1%+6.1% +0.9%
3 months +115.3%+12.2%+15.9% +5.9%
6 months +68.6%+62.7%+34.3% +8.5%
Year to date +45.3%+65.9%+0.6% +13.3%
1 year -42.7%+73.3%+6.0% +12.4%
3 years -99.9%+120.0%-22.4% +88.1%
3 years, per year -90.0%+30.1%-8.1% +23.5%
5 years —+80.7%-18.5% +68.2%
5 years, per year —+12.6%-4.0% +11.0%
10 years —+216.9%+16.3% +263.4%
10 years, per year —+12.2%+1.5% +13.8%

Risk

MeasureSKYAACUBDXSPY
Volatility, 1Y 105.9%30.7%31.8% 12.7%
Downside volatility, 1Y 104.7%24.2%33.1% 12.7%
Beta vs S&P 500, 1Y 2.600.240.34 1.00
Return / volatility, 1Y -0.402.390.19 0.98
Max drawdown, 5Y -100.0%-43.5%-50.4% -25.4%
From 52-week high -42.7%0.0%-7.1% -0.9%
52-week high $5.15$66.87$210.02 $779.14
52-week low $0.95$35.50$140.71 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleSKYAACUBDX
P/E now vs peer median -0.7xmedian 28.8x 24.8xmedian 28.8x 57.0xmedian 28.8x
P/S now vs peer median 1,095xmedian 3.0x 1.2xmedian 3.0x 2.3xmedian 3.0x
EV/EBITDA now vs peer median —median 17.4x —median 17.4x 13.9xmedian 17.4x
P/FCF now vs peer median —median 25.7x 15.8xmedian 25.7x 16.6xmedian 25.7x
P/B now vs peer median 1.4xmedian 2.4x 2.1xmedian 2.4x 2.2xmedian 2.4x
PEG now vs peer median 0.01median 1.03 —median 1.03 -3.90median 1.03

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsSKYAACUBDX
Revenue $194.22K – $23.25B
Gross profit $321.93K – $10.91B
Operating income -$289.52M – $2.48B
Net income -$307.71M – $941.00M
Free cash flow – – $3.20B
R&D $399.91K – $1.37B
EPS (diluted) $-4.27 – $3.42
Cash & equivalents $12.07M $7.94M $708.00M
Total debt – – $72.81B
Shares (diluted) 72.09M 4.14M 275.16M
Enterprise value $171.38M $256.37M $50.31B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricSKYAACUBDX
P/E -0.7x 24.8x 57.0x
P/FCF – 15.8x 16.6x
P/Operating cash flow – – 13.4x
P/S 1,095x 1.2x 2.3x
P/B 1.4x 2.1x 2.2x
P/Tangible book 16.4x 2.8x 2.2x
EV/EBITDA – – 13.9x
EV/EBIT -0.7x – 27.9x
EV/Revenue 1,033x – 3.0x
EV/FCF – – 21.6x
EV/Operating cash flow – – 17.5x
PEG (3Y EPS CAGR) 0.01 – -3.90

Growth

14 metrics
MetricSKYAACUBDX
Revenue growth (1Y) 108.9% – 17.4%
Revenue CAGR (3Y) 23.8% – 6.9%
Gross profit growth (1Y) – – 23.7%
Gross profit CAGR (3Y) – – 8.5%
Operating income growth (1Y) -5,525% – 13.0%
Operating income CAGR (3Y) -212.8% – 3.3%
Net income growth (1Y) -42,440% – -40.6%
Net income CAGR (3Y) -238.0% – -17.3%
EPS growth (1Y) -487.2% – -38.0%
EPS CAGR (3Y) -84.2% – -14.6%
Operating cash flow growth (1Y) – – 43.5%
Operating cash flow CAGR (3Y) – – 14.5%
Free cash flow growth (1Y) – – 54.2%
Free cash flow CAGR (3Y) – – 22.5%

Profitability

14 metrics
MetricSKYAACUBDX
Gross margin 165.8% – 46.9%
EBITDA margin – – 21.4%
Operating margin -149,065% – 10.7%
Pretax margin -151,352% – 8.4%
Net margin -158,431% – 4.0%
FCF margin – – 13.8%
Operating cash flow margin – – 17.0%
Return on equity -140.2% – 3.9%
Return on assets -137.6% – 1.9%
Return on invested capital – – 5.3%
Return on capital employed -136.7% – 6.0%
Asset turnover 0.0x – 0.5x
Cash conversion (OCF / net income) – – 4.2x
Stock comp / revenue 48,037% – 1.2%

Financial Health

11 metrics
MetricSKYAACUBDX
Debt / assets – – 33.1%
Debt / equity – – 0.7x
Net debt / EBITDA – – 3.2x
Debt / FCF – – 5.2x
Liabilities / assets 1.9% 39.9% 51.9%
Equity / assets 98.1% 60.1% 48.1%
Interest coverage – – 4.2x
Current ratio 5.3x 3.9x 0.9x
Quick ratio 4.4x – 0.3x
Cash ratio 4.2x – 0.1x
Altman Z-score 31.97 – 2.29

Shareholder Returns

7 metrics
MetricSKYAACUBDX
Dividend yield – 1.0% 2.2%
Net buyback yield – – 4.7%
Shareholder yield – 1.0% 6.9%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusSKYAACUBDX
Forward P/E 0.0xFY2026 24.3xFY2026 15.0xFY2026
EPS, next fiscal year $2,362.06FY2026 $2.75FY2026 $12.99FY2026
EPS growth, next FY – +10.4%FY2026 +14.8%FY2026
EPS growth, the year after – +4.0% -2.9%
Revenue, next fiscal year $70.01MFY2026 $217.65MFY2026 $18.11BFY2026
Revenue growth, next FY +34,200.1%FY2026 +10.7%FY2026 -17.1%FY2026
Revenue growth, the year after +17.5% +0.7% +11.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersSKYAACUBDX
Held by institutions – 73.5% 96.1%
Institutions holding – 84 1,442
Change in shares held, QoQ – +1.3% +0.6%
Institutions buying – 47 688
Institutions selling – 21 543
Buyers to sellers – 2.24 1.27

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

SKYAACUBDX
SKYA 1.00 0.00 0.11
ACU 0.00 1.00 0.20
BDX 0.11 0.20 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, SKYA, ACU and BDX?

Becton Dickinson (BDX) is the largest by market capitalisation: SkyAI (SKYA) $212.68M, Acme United (ACU) $256.37M, Becton Dickinson (BDX) $53.16B.

Which stock is cheaper, SKYA, ACU and BDX?

Acme United (ACU) trades on the lowest price-to-earnings ratio (SkyAI (SKYA) -0.7x, Acme United (ACU) 24.8x, Becton Dickinson (BDX) 57.0x). On next year's consensus earnings, SkyAI (SKYA) is cheapest (SkyAI (SKYA) 0.0x, Acme United (ACU) 24.3x, Becton Dickinson (BDX) 15.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

SkyAI (SKYA) grew revenue fastest over the trailing twelve months: SkyAI (SKYA) +108.9%, Becton Dickinson (BDX) +17.4%.

Which company is more profitable?

Becton Dickinson (BDX) has the highest net margin (SkyAI (SKYA) -158,431.4%, Becton Dickinson (BDX) 4.0%).

Which stock has performed better?

Over the past year Acme United (ACU) returned the most: SkyAI (SKYA) -42.7%, Acme United (ACU) +73.3%, Becton Dickinson (BDX) +6.0%. Over five years, Acme United (ACU) compounded fastest (Acme United (ACU) +12.6%/yr, Becton Dickinson (BDX) -4.0%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Becton Dickinson (BDX) has the highest dividend yield: Acme United (ACU) 0.96%, Becton Dickinson (BDX) 2.15%. SkyAI (SKYA) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Acme United (ACU) has been the steadiest (SkyAI (SKYA) 105.9%, Acme United (ACU) 30.7%, Becton Dickinson (BDX) 31.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, SKYA, ACU and BDX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Acme United (ACU) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.